We are here to serve the community and we want to keep you informed about the cyber event that happened to our network on May 9. The event remains under investigation. We continue to bring systems back online and are closer to resuming all operations.
If you already have a Norton EpicLink account, click on “Log In” below. If you are a provider and would like to request a Norton EpicLink account, click on “New User Request” below. You will be contacted and asked to fill out security forms to gain access. Please allow five to seven business days to process the request.
Refer a patient. Make referrals to adult specialty providers and diagnostic services.
View real-time referral status. Easily track the status of your referrals.
Help ensure continuity of care. Since Norton EpicLink is web-based, information is available almost instantly for any patient encounter across the Norton Healthcare system, including hospitalizations, emergency visits and specialist referrals.
Safely communicate with providers. Securely send HIPAA-compliant messages to Norton Healthcare providers.
Access patient information anywhere. With Norton EpicLink, you have view-only access anywhere you have internet service. View clinical data including radiology and procedure reports, hospital discharge summaries, current medication lists, patient demographics and coverage data.
Customize views and set notifications. Use filters to control what information you and your office staff see in Norton EpicLink and set up event notifications about your patients who access Norton Healthcare services.
Manage MyClinic. You can designate a manager to add and delete your practice’s Norton EpicLink users.
After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity [...]
Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]
Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]
Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric [...]
Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in […]